Pharma Market Access Insights - from Petauri Evidence

Global Pricing and Market Access – Strategies for Success in an Evolving Landscape

Transforming Global Market Access: Smarter Resource Management with Local Affiliates

Communicating value to US Payers: Insights for Pharma and Medtech

Navigating market access: Launch strategies and health economic modelling for medical devices

Navigating US payer evidence needs to optimise market access

Best practice RWE approaches to support economic modelling for HTA

NHS winter planning 2024–25 – Engaging with NHS decision-makers through Autumn to Christmas

De-mystifying the NHS – What you need to know about the NHS as a market for your health technology

NHS primary care panel – the GP Contract and Operational Planning Guidance

Engage NHS healthcare decision-makers with RWD

Market access and reimbursement in Canada – changes at CADTH

Rare Disease market access in the MENA and Nordic regions

How does funding flow in NHSE Regions?

NHS policy for 2024/25: strategy and engagement in a world of uncertainty (recorded in Jan 2024)

De-mystifying health economic model classifications and structures

Evidence strategy for Medical Technologies and Diagnostics

How to set your Pharma or Medtech product up for success in the US market

What's happening with specialised commissioning in the NHS?

Integrated care in NHS Wales – what can England learn from its neighbour?

Market access in Italy: Reforms at AIFA

Unmet need in NHS primary care – How can industry best support PCN leaders?

Population health management: a community effort across health and life sciences

Artificial intelligence (AI) in clinical trials: Implications for evidence synthesis and market access

6 areas of UK health policy for Medtech to pay attention to

Market access in the German speaking markets

The role of nursing in driving digital change in the NHS

Market access for digital therapies and digital medicines

A global market access journey in cannabinoid pharmaceuticals

Primary Care and ICBs – what is the next step in the integration journey?

Data-led transformation in the NHS - partnering to optimise patient care

Innovating for better health – research, collaboration and innovation in the NHS

Healthcare, economics and society – unlocking NHS collaboration

Specialised Commissioning in the NHS – What do you need to know now

Why are we waiting? - Pressures facing the NHS and how to deliver change

Priority setting in primary care - NHS insights

Integrated Care Systems go live in the NHS - reflections after 3 weeks

Clinical Pharmacists – exploring the scope, capabilities, and potential of this evolving NHS role

Transforming systems and care pathways for an integrated NHS

Digital value payer communication tools: How to meet the needs of your internal stakeholders and customers

Population to Person: How will the NHS translate population health management into impactful, person-centred service change?

Planning in a volatile environment: how will the NHS reconcile its competing priorities and operational planning to meet its challenges?

The evolving NHS: How can Pharma and Medtech support the NHS in 2022? - NHS Insights Panel Discussion

Optimising the NHS – How will medicines be valued in integrated systems?

Rare disease market access - strategic and tactical challenges facing orphan medicines entering Europe

A new paradigm for the NHS: Partnering to deliver lasting and meaningful care improvements - with Dr Phil Webb (Chief Executive of Respiratory Innovation Wales)

Innovations to address health inequalities in the NHS and how Pharma and Medtech can help

The hidden heroes of the NHS - The role of ambulance Trusts in keeping patients and systems moving

Population to person - How will the voice of the individual drive health and care development?

Know your Place - where will power really sit in the new NHS - with Dr Steven Michael OBE

Health Economic Modelling for MedTech Innovation - What, Why and How